Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
3.120
-0.300 (-8.77%)
At close: Dec 5, 2025, 4:00 PM EST
3.200
+0.080 (2.56%)
After-hours: Dec 5, 2025, 7:56 PM EST
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $15.37 million as of December 5, 2025. Its market cap has decreased by -59.28% in one year.
Market Cap
15.37M
Enterprise Value
16.26M
1-Year Change
-59.28%
Ranking
Category
Stock Price
$3.12
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $15.37M, a decrease of -82.66%. That is a compound annual growth rate of -32.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 15.37M | -57.79% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |